Association of lipoprotein(a) with long‐term mortality following coronary angiography or percutaneous coronary intervention

• Published in: Clinical cardiology (Mahwah, N.J.) Vol. 40; no. 9; pp. 674 - 678
• Main Authors: Feng, Zhe, Li, Hua‐long, Bei, Wei‐jie, Guo, Xiao‐sheng, Wang, Kun, Yi, Shi‐xin, Luo, De‐mou, Li, Xi‐da, Chen, Shi‐qun, Ran, Peng, Chen, Peng‐yuan, Islam, Sheikh Mohammed Shariful, Chen, Ji‐yan, Liu, Yong, Zhou, Ying‐ling
• Format: Journal Article
• Language: English
• Published: New York Wiley Periodicals, Inc 01.09.2017; John Wiley & Sons, Inc
• Subjects: Aged; Angioplasty; Biomarkers - blood; Chi-Square Distribution; Clinical Investigations; Coronary Angiography; Coronary Angiography - adverse effects; Coronary Angiography - mortality; Coronary Artery Disease - blood; Coronary Artery Disease - diagnostic imaging; Coronary Artery Disease - mortality; Coronary Artery Disease - therapy; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Lipoprotein(a); Lipoprotein(a) - blood; Male; Medical imaging; Middle Aged; Mortality; Multivariate Analysis; Percutaneous Coronary Intervention; Percutaneous Coronary Intervention - adverse effects; Percutaneous Coronary Intervention - mortality; Predictive Value of Tests; Proportional Hazards Models; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome; Up-Regulation; Coronary Angiography; Lipoprotein(a); Mortality; Percutaneous Coronary Intervention

Background There is no consistent evidence to suggest the association of plasma lipoprotein(a) (Lp[a]) with long‐term mortality in patients undergoing coronary angiography (CAG) or percutaneous coronary intervention (PCI). Hypothesis Level of Lp(a) is associated with long‐term mortality following CA...